CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2018 EXECUTIVE SUMMARY

Endocr Pract. 2018 Jan;24(1):91-120. doi: 10.4158/CS-2017-0153. Epub 2018 Jan 17.
No abstract available

Publication types

  • Consensus Development Conference

MeSH terms

  • Algorithms*
  • Comorbidity
  • Counseling
  • Diabetes Mellitus, Type 2 / epidemiology
  • Diabetes Mellitus, Type 2 / therapy*
  • Diet Therapy*
  • Disease Management
  • Endocrinology
  • Exercise*
  • Humans
  • Hyperlipidemias / drug therapy
  • Hyperlipidemias / epidemiology
  • Hypertension / drug therapy
  • Hypertension / epidemiology
  • Hypoglycemic Agents / therapeutic use*
  • Hypolipidemic Agents / therapeutic use
  • Life Style
  • Obesity / epidemiology
  • Obesity / therapy
  • Patient Education as Topic
  • Prediabetic State
  • Sleep
  • Smoking Cessation
  • Societies, Medical
  • Triazines / therapeutic use
  • United States

Substances

  • Hypoglycemic Agents
  • Hypolipidemic Agents
  • Triazines
  • anitrazafen